Recruiting A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma NCT06057935 Conditions Adenoma, Lung Diseases, Lung Neoplasms, +14 more Locations University of Chicago (Data Collection Only) — Chicago, Illinois, United States University of Michigan (Data Collection Only) — Ann Arbor, Michigan, United States Washington University (Data Collection Only) — St Louis, Missouri, United States University of Nebraska (Data collection only) — Omaha, Nebraska, United States View all 13 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed αDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface Malignancies NCT02151448 Conditions Abdominal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +7 more Locations UPMC Hillman Cancer Center — Pittsburgh, Pennsylvania, United States View Trial Details
Completed Erlotinib Hydrochloride in Treating Patients With Malignant Peritoneal Mesothelioma NCT01592383 Conditions Malignant Peritoneal Mesothelioma Locations University of Chicago Comprehensive Cancer Center — Chicago, Illinois, United States View Trial Details
